相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of a founder EPCAM deletion in Spanish Lynch syndrome families
P. Mur et al.
CLINICAL GENETICS (2014)
Epigenetic mechanisms in the pathogenesis ofLynch syndrome
P. Peltomaki
CLINICAL GENETICS (2014)
The MLH1 c.-27C>A and c.85G>T variants are linked to dominantly inherited MLH1 epimutation and are borne on a European ancestral haplotype
Chau-To Kwok et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2014)
Lynch Syndrome in high risk Ashkenazi Jews in Israel
Yael Goldberg et al.
FAMILIAL CANCER (2014)
A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns
Iolanda Borelli et al.
FAMILIAL CANCER (2014)
Next Generation Sequencing and the Future of Genetic Diagnosis
Katja Lohmann et al.
NEUROTHERAPEUTICS (2014)
The Norwegian PMS2 founder mutation c.989-1G > T shows high penetrance of microsatellite instable cancers with normal immunohistochemistry
Eli Marie Grindedal et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2014)
The MSH2 c.388_389del mutation shows a founder effect in Portuguese Lynch syndrome families
M. Pinheiro et al.
CLINICAL GENETICS (2013)
Balearic archipelago: three islands, three beta-thalassemia population patterns
H. Lopez-Escribano et al.
CLINICAL GENETICS (2013)
Recurrent and founder mutations in the PMS2 gene
J. Tomsic et al.
CLINICAL GENETICS (2013)
A unique MSH2 exon 8 deletion accounts for a major portion of all mismatch repair gene mutations in Lynch syndrome families of Sardinian origin
Iolanda Borelli et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2013)
Foreword for 100 years of Lynch syndrome
Henry T. Lynch et al.
FAMILIAL CANCER (2013)
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
Hans F. A. Vasen et al.
GUT (2013)
A Comprehensive Focus on Global Spectrum of BRCA1 and BRCA2 Mutations in Breast Cancer
Fatemeh Karami et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Mutation spectrum in South American Lynch syndrome families
Mev Dominguez-Valentin et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2013)
A novel germline MLH1 mutation causing Lynch Syndrome in patients from the Republic of Macedonia
Marija Hiljadnikova-Bajro et al.
CROATIAN MEDICAL JOURNAL (2012)
Cancer risks and immunohistochemical profiles linked to the Danish MLH1 Lynch syndrome founder mutation
Christina Therkildsen et al.
FAMILIAL CANCER (2012)
An American founder mutation in MLH1
Jerneja Tomsic et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
ColoSeq Provides Comprehensive Lynch and Polyposis Syndrome Mutational Analysis Using Massively Parallel Sequencing
Colin C. Pritchard et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
Dominantly Inherited Constitutional Epigenetic Silencing of MLH1 in a Cancer-Affected Family Is Linked to a Single Nucleotide Variant within the 5′UTR
Megan P. Hitchins et al.
CANCER CELL (2011)
Characterization of New Founder Alu-Mediated Rearrangements in MSH2 Gene Associated with a Lynch Syndrome Phenotype
Lucia Perez-Cabornero et al.
CANCER PREVENTION RESEARCH (2011)
Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndrome
L. Raskin et al.
CLINICAL GENETICS (2011)
Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals
Mev Dominguez Valentin et al.
FAMILIAL CANCER (2011)
Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation
Patrizia Lastella et al.
FAMILIAL CANCER (2011)
Novel MLH1 duplication identified in Colombian families with Lynch syndrome
Virginia Alonso-Espinaco et al.
GENETICS IN MEDICINE (2011)
A novel exonic rearrangement affecting MLH1 and the contiguous LRRFIP2 is a founder mutation in Portuguese Lynch syndrome families
Manuela Pinheiro et al.
GENETICS IN MEDICINE (2011)
LOVD v.2.0: The Next Generation in Gene Variant Databases
Ivo F. A. C. Fokkema et al.
HUMAN MUTATION (2011)
Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome
Monika Morak et al.
JOURNAL OF MEDICAL GENETICS (2011)
MLH1 Founder Mutations with Moderate Penetrance in Spanish Lynch Syndrome Families
Ester Borras et al.
CANCER RESEARCH (2010)
Founder effect of a pathogenic MSH2 mutation identified in Spanish families with Lynch syndrome
M. Menendez et al.
CLINICAL GENETICS (2010)
HLA-A3-B14 and the origin of the haemochromatosis C282Y mutation: founder effects and recombination events during 12 generations in a Scandinavian family with major iron overload
K. Sigvard Olsson et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Constitutional mismatch repair-deficiency syndrome
Katharina Wimmer et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Founder Mutations in Xeroderma Pigmentosum
Deborah Tamura et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers
Laura Baglietto et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Detection of genetic alterations in hereditary colorectal cancer screening
Marta Pineda et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2010)
A novel pathogenic MLH1 missense mutation, c.112A > C, p.Asn38His, in six families with Lynch syndrome
Els van Riel et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2010)
Germ line MLH1 and MSH2 mutations in Taiwanese Lynch syndrome families: characterization of a founder genomic mutation in the MLH1 gene
R. Tang et al.
CLINICAL GENETICS (2009)
Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications
H. T. Lynch et al.
CLINICAL GENETICS (2009)
A homozygote splice site PMS2 mutation as cause of Turcot syndrome gives rise to two different abnormal transcripts
Wenche Sjursen et al.
FAMILIAL CANCER (2009)
EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome
Glenn E. Palomaki et al.
GENETICS IN MEDICINE (2009)
High Frequency of Exon Deletions and Putative Founder Effects in French Canadian Lynch Syndrome Families
George Chong et al.
HUMAN MUTATION (2009)
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3 ' exons of TACSTD1
Marjolijn J. L. Ligtenberg et al.
NATURE GENETICS (2009)
Origins and prevalence of the American Founder Mutation of MSH2
Mark Clendenning et al.
CANCER RESEARCH (2008)
The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations
Leigha Senter et al.
GASTROENTEROLOGY (2008)
A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting
D. Ramsoekh et al.
GUT (2008)
A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome
M. Clendenning et al.
JOURNAL OF MEDICAL GENETICS (2008)
The m531 mutation in CDKN2A is a founder mutation that predominates in melanoma patients with Scottish ancestry
Julie Lang et al.
GENES CHROMOSOMES & CANCER (2007)
Brief report:: Inheritance of a cancer-associated MLH1 germ-line epimutation
Megan P. Hitchins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC
A. Stella et al.
CLINICAL GENETICS (2007)
Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer
Maurizio Ponz De Leon et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)
New founding mutation in MSH2 associated with hereditary nonpolyposis colorectal cancer syndrome on the Island of Tenerife
Vicente Medina-Arana et al.
CANCER LETTERS (2006)
Cancer risks for mismatch repair gene mutation carriers: A population-based early onset case-family study
MA Jenkins et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
The matrilineal ancestry of Ashkenazi Jewry: Portrait of a recent founder event
DM Behar et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
New developments in Lynch syndrome (hereditary nonpolyposis colorectal cancer) and mismatch repair gene testing
SB Gruber
GASTROENTEROLOGY (2006)
American founder mutation for Lynch syndrome - Prevalence estimates and implications
HT Lynch et al.
CANCER (2006)
Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome
K Cederquist et al.
CLINICAL GENETICS (2005)
The HNPCC associated MSH2*1906G→C founder mutation probably originated between 1440 CE and 1715 CE in the Ashkenazi Jewish population
S Sun et al.
JOURNAL OF MEDICAL GENETICS (2005)
Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 german families suspected of hereditary nonpolyposis colorectal cancer
E Mangold et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer -: art. no. e22
P Vahteristo et al.
JOURNAL OF MEDICAL GENETICS (2005)
Presymptomatic diagnosis using a deletion of a single codon in families with hereditary non-polyposis colorectal cancer
RS Ripa et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
MSH2 c. 1452-1455delAATG is a founder mutation and an important cause of hereditary nonpolyposis colorectal cancer in the southern Chinese population
TL Chan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
A founder MLH1 mutation in families from the districts of Modena and Reggio-Emilia in northern Italy with hereditary non-polyposis colorectal cancer associated with protein elongation and instability -: art. no. e34
O Caluseriu et al.
JOURNAL OF MEDICAL GENETICS (2004)
A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States
HT Lynch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Putative common origin of two MLH1 mutations in Italian-Quebec hereditary non-polyposis colorectal cancer families
I Thiffault et al.
CLINICAL GENETICS (2004)
Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations:: Impact on counseling and surveillance
YMC Hendriks et al.
GASTROENTEROLOGY (2004)
Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations:: The German hereditary nonpolyposis colorectal cancer consortium
J Plaschke et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States:: High mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene
A Wagner et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Genetic anthropology of the colorectal cancer-susceptibility allele APC I1307K: Evidence of genetic drift within the Ashkenazim
BL Niell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
The founder mutation MSH2*1906G→C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population
WD Foulkes et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
BLM heterozygosity and the risk of colorectal cancer
SB Gruber et al.
SCIENCE (2002)
DMLE+: Bayesian linkage disequilibrium gene mapping
JP Reeve et al.
BIOINFORMATICS (2002)
Molecular and clinical characteristics of MSH6 variants: An analysis of 25 index carriers of a germline variant
MJW Berends et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
High-resolution multipoint linkage-disequilibrium mapping in the context of a human genome sequence
B Rannala et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
A novel germline 1.8-kb deletion of hMLH1 mimicking alternative splicing:: a founder mutation in the Chinese population
TL Chan et al.
ONCOGENE (2001)
Using linked markers to infer the age of a mutation
B Rannala et al.
HUMAN MUTATION (2001)
Recurrent germline mutation in MSH2 arises frequently de novo
DC Desai et al.
JOURNAL OF MEDICAL GENETICS (2000)
分享论文
